Delivery Order SPE2DB20D2104-SPE2DB26FMBFL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of BRILINTA 60 mg tablets (quantity 60s) with a ceiling value of $6,438.32. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count units) on September 26, 2025, with a ceiling value of $3,626.64 and completion deadline of September 29, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of 60 tablets of BRILINTA 90 mg at a firm fixed price of $10,575.36. This non-set-aside, competitively awarded contract is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) valued at $3,759.72, with an ultimate completion date of October 27, 2025. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with performance to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the open competition process...
- The Defense Logistics Agency awarded a delivery order valued at $16,556.28 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count units) on October 23, 2025, with completion scheduled for October 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a ceiling value of $3,983.15. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by October 31, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $3,329.04. The delivery order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $11,180.17 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,551.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,326.35. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBFLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of BRILINTA 90 mg tablets (60-count packaging) valued at $3,667.20 under a firm fixed-price arrangement. The delivery order carries an ultimate completion date of October 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was not set-aside and was competitively awarded, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements in open competition. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's contract performance demonstrates versatility in fulfilling federal medical supply needs across multiple therapeutic domains through flexible delivery order mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/29/25 |